Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online February 25, 2008
Diabetes 57:1321-1330, 2008
DOI: 10.2337/db07-1129
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Figures
Right arrow All Versions of this Article:
db07-1129v1
57/5/1321    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burton, A. R.
Right arrow Articles by Vignali, D. A.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burton, A. R.
Right arrow Articles by Vignali, D. A.A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

On the Pathogenicity of Autoantigen-Specific T-Cell Receptors

Amanda R. Burton1, Erica Vincent1, Paula Y. Arnold1, Greig P. Lennon1, Matthew Smeltzer2, Chin-Shang Li3, Kathryn Haskins4, John Hutton5, Roland M. Tisch6, Eli E. Sercarz7, Pere Santamaria8, Creg J. Workman1, and Dario A.A. Vignali1

1 Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee
2 Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee
3 Division of Biostatistics, Department of Public Health Sciences, University of California, Davis, Californnia
4 Department of Immunology, University of Colorado Health Sciences Center, Denver, Colorado
5 Barbara Davis Center for Childhood Diabetes, University of Colorado, Aurora, Colorado
6 Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina
7 Division of Immune Regulation, Torrey Pines Institute for Molecular Studies, San Diego, California
8 Julia McFarlane Diabetes Research Centre and the Department of Microbiology and Infectious Diseases, Institute of Infection, Immunity and Inflammation, University of Calgary, Calgary, Alberta, Canada

Corresponding author: Dr. Dario Vignali, Department of Immunology, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105-2794. E-mail: dario.vignali{at}stjude.org

Abbreviations: FACS, fluorescence-activated cell sorter; GFP, green fluorescent protein; HBSS, Hank's Balanced Salt Solution; FBS, fetal bovine serum; IA2, insulinoma-associated protein 2; ILN, inguinal lymph node; HEL, Hen egg white lysozyme; PE, phycoerythrin; PLN, pancreatic lymph node; TCR, T-cell receptor

OBJECTIVE—Type 1 diabetes is mediated by T-cell entry into pancreatic islets and destruction of insulin-producing β-cells. The relative contribution of T-cells specific for different autoantigens is largely unknown because relatively few have been assessed in vivo.

RESEARCH DESIGN AND METHODS—We generated mice possessing a monoclonal population of T-cells expressing 1 of 17 T-cell receptors (TCR) specific for either known autoantigens (GAD65, insulinoma-associated protein 2 (IA2), IA2β/phogrin, and insulin), unknown islet antigens, or control antigens on a NOD.scid background using retroviral-mediated stem cell gene transfer and 2A-linked multicistronic retroviral vectors (referred to herein as retrogenic [Rg] mice). The TCR Rg approach provides a mechanism by which T-cells with broad phenotypic differences can be directly compared.

RESULTS—Neither GAD- nor IA2-specific TCRs mediated T-cell islet infiltration or diabetes even though T-cells developed in these Rg mice and responded to their cognate epitope. IA2β/phogrin and insulin-specific Rg T-cells produced variable levels of insulitis, with one TCR producing delayed diabetes. Three TCRs specific for unknown islet antigens produced a hierarchy of insulitogenic and diabetogenic potential (BDC-2.5 > NY4.1 > BDC-6.9), while a fourth (BDC-10.1) mediated dramatically accelerated disease, with all mice diabetic by day 33, well before full T-cell reconstitution (days 42–56). Remarkably, as few as 1,000 BDC-10.1 Rg T-cells caused rapid diabetes following adoptive transfer into NOD.scid mice.

CONCLUSIONS—Our data show that relatively few autoantigen-specific TCRs can mediate islet infiltration and β-cell destruction on their own and that autoreactivity does not necessarily imply pathogenicity.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.